Latest Breaking News On - Innovazione cardiovascolare - Page 1 : comparemela.com

DCB in STEMI Match DES Through 5 Years: REVELATION

The trial, though not powered for clinical outcomes, hints at yet another setting where it may be possible to leave nothing behind.

United statesNoord hollandUnited kingdomAsia pacificBernardo corteseSanderr nieheXience abbottPantera luxBoston scientificDrug administrationLatin americaFondazione ricercaInnovazione cardiovascolareOne event after

Comparing DCBs in De Novo CAD: Drugs, Design Matter

At TCT 2023, two studies of sirolimus- vs paclitaxel-coated devices reached different conclusions about 6-month late lumen loss.

New south walesSonya nadine burgessBernardo corteseBruno schellerHomburg saarPatrickw serruysPhd university of galwayMd saarland universityMd san raffaele scientific institutePhd university of new south walesConcept medicalSequent please neoSequent pleaseSaarland universityCardiovascular interventionsFondazione ricerca

Comparing DCBs in De Novo CAD: Drugs, Design Matters

At TCT 2023, two studies of sirolimus- vs paclitaxel-coated devices reached different conclusions about 6-month late lumen loss.

New south walesPatrickw serruysHomburg saarBruno schellerBernardo corteseSonya nadine burgessMd san raffaele scientific institutePhd university of galwayMd saarland universityPhd university of new south walesConcept medicalSequent please neoSequent pleaseSaarland universityCardiovascular interventionsFondazione ricerca

Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling – Padovanews

Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling – Padovanews
padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.

San carloPaderno dugnanoBernardo corteseRoxana mehranPeter smithAlessandro sciahbasiAlexandre abizaidTorre hernandezRicercae innovazione cardiovascolareStefano rigattieriFernando alfonsoMagic touch concept medical incInnovazione cardiovascolareControlled trialNative coronary vesselsNative coronary vessel treatment

Concept Medical Inc : Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling

MILANO, Italy, Jan. 28, 2022 /PRNewswire/ FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano, focused on cardiovascular research, reports the first patient enrolment of the TRANSFORM

San carloPaderno dugnanoBernardo corteseRoxana mehranPeter smithAlessandro sciahbasiAlexandre abizaidTorre hernandezRicercae innovazione cardiovascolareKostenloser wertpapierhandelStefano rigattieriFernando alfonsoMagic touch concept medical incInnovazione cardiovascolareControlled trialNative coronary vessels